Skip to main content
. 2022 Oct 10;15:5801–5814. doi: 10.2147/JIR.S385491

Figure 5.

Figure 5

The association between ST6GAL1 mRNA expression and liver inflammation status. (AC) ST6GAL1 expression of HCC tissues in no-viral hepatitis (VH) and VH groups (A), no-alcoholic liver disease (ALD) and ALD groups (B), and no-non-alcoholic fatty liver disease (NAFLD) and NAFLD groups (C) in the TCGA-HCC database; (D and E) Correlation between ST6GAL1 mRNA expression and alanine aminotransferase (ALT, (D)), and aspartate aminotransferase (AST, (E)) levels in the GSE83148 dataset; (F and G) Correlation between ST6GAL1 mRNA expression and ALT (F) and AST (G) levels in the GSE84044 dataset; (H) Expression of ST6GAL1 among hepatitis patients with Scheuer grades of G0, G1-G4 in the GSE84044 dataset; (I) ST6GAL1 expression of normal liver, chronic inflammatory liver, cirrhotic livers, early HCC, and advanced HCC in GSE54238 dataset. *p < 0.05, **p < 0.01, ***p < 0.001.